Company to continue development of efzofitimod in pulmonary sarcoidosis incorporating FDA feedback.Company plans to submit IND in June 2026 for ...
First clinical data from PRMT5/RAS(ON) combination trial to be presented in 2026Cash position of $380 million as of March 31, 2026, with runway ...
Company to continue development of efzofitimod in pulmonary sarcoidosis incorporating FDA feedback. Company plans to submit IND in June 2026 for new Phase 3 study of efzofitimod in patients with chron ...
Birkin bag maker Hermes reported a slowdown in sales growth for the first quarter as the war in Iran clouds the sector's rebound. The French company booked revenue of 4.07 billion euros ($4.80 billion ...
ASHBURN, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late ...
Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrome - Submitted Application to Japanese MHLW for Orphan Drug Designation (ODD) for QRX003; MHLW Confirme ...
aTyr Pharma (NASDAQ:ATYR) said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after ...
Starting with MU-3.0 release, MU-StarSeeker is built to disrupt that traditional model by turning isolated research steps ...
President Donald Trump is committing to his naval blockade against Iran on Tuesday as the U.S. and Iran plan to resume peace talks this week. Negotiations are set to revolve around Iran's nuclear ...
Ladies and gentlemen, welcome to Sienna Senior Living Incorporated's First Quarter 2026 Conference Call. Today's call is hosted by Nitin Jain, President and Chief Executive Officer; and David Hung, ...
The roller coaster capital of the world is back as Cedar Point opens for the 2026 season on Saturday, May 9.
While museums all across the U.S. will be celebrating our nation's 250th birthday, top museums are doing some creative, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results